@kandymarsy Profile picture

Khandan Keyomarsi

@kandymarsy

Professor at UT MD Anderson Cancer Center, Breast Cancer Research, targeting triple negative breast cancer

Similar User
Dr. Ron DePinho photo

@RonDePinho

Nicholas Navin photo

@nicholas_navin

Giulio Draetta photo

@DraettaG

Hussein Tawbi, MD, PhD photo

@HTawbi_MD

Linghua Wang, MD, PhD photo

@IamLinghua

Anne Tsao, MD, MBA photo

@AnneTsao2

David S. Hong MD photo

@DavidHongMD

Matthew Gubin photo

@GubinMatthew

Kelly K Hunt photo

@KellyKhunt

Brette Peyton photo

@bnpeyton

GSBS Community Outreach photo

@GSBS_Outreach

Emily Roarty, PhD photo

@EmilyRoarty

Chandra Bartholomeusz, MD, PhD photo

@cbartholomeusz1

Tim Heffernan photo

@timheff5

Hannah Wingate, PhD photo

@hannahwingate7

Khandan Keyomarsi Reposted

Applications for our @MDAndersonNews 2025 CATALYST Summer Training Program are open! This is an excellent opportunity for high school, undergraduate, graduate and medical students to gain exposure to cancer research. More information: bit.ly/3RcwJCH @kandymarsy @swatowic


Khandan Keyomarsi Reposted

“The call from Stockholm is mythic in the world of science.” New medicine laureate Gary Ruvkun has received a prank call or two in the past, but today’s was genuine. We talked to him minutes after he heard the news of his #NobelPrize.


Khandan Keyomarsi Reposted

The Keyomarsi lab (@kandymarsy) and their collaborators found that low molecular weight cyclin E confers a vulnerability to PKMYT1 inhibition in #TNBC. 💡 Learn more in @CR_AACR: bit.ly/4elH6gP

Tweet Image 1

Exciting work from our lab reporting that TNBCs that do not respond to chemotherapy have high LMW-E levels that upregulates and stabilizes PKMYT1, leading to enhanced p-CDK1 in TNBCs, which are now more sensitive to the PKMYT1 inhibitor RP-6306. bit.ly/4elH6gP

Tweet Image 1

Remember those days! So care free and magical.

This post is unavailable.

A huge congratulations to Kelly. So well deserved. @KellyKhunt @MDAndersonNews

Huge congratulations to Dr. Hunt for being inducted into the Giants of Cancer Care program at ASCO! We are proud of her incredible and well-deserved achievement. Dr. Hunt’s dedication and hard work have truly made a significant impact in oncology. @KellyKhunt #endcancer #ASCO24

Tweet Image 1


An amazing scientist, physician and teacher who always sees the glass half full.

An amazing teacher, physician, and scientist...@KellyKhunt - thank you for always talking through cases with me and taking the time to discuss breast cancer management every year with me before ABSITE. I am so blessed to learn from the best. 🩷 #ListenUp



Khandan Keyomarsi Reposted

Final FY24 funding paylines for competing R01 grants: Non-early stage investigators NCI 10th percentile NIDDK 13th percentile NIA 16th percentile Early stage investigators NCI 17th percentile NIDDK 25th percentile NIA…


After a very productive day presenting 2 studies at #AACR24 which attracted a lot of interest on the @BlueprintMeds CDK2 inhibitor, we got together with the KeyHunt lab alumni for some Sushi. @lindseyluo419 @junay_14 @ndttuyen @KellyKhunt

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Khandan Keyomarsi Reposted

Working with @MDAndersonNews, we aim to uncover the broad potential of CDK2 inhibition in cancer treatment. At #AACR24, we reported preclinical breast cancer data showing the activity of our investigational CDK2 inhibitor in combination with a CDK4/6 inhibitor.

Tweet Image 1

Khandan Keyomarsi Reposted

Research led by Drs. Linjie Luo, Khandan Keyomarsi and Kelly Hunt (4622) examines anti-tumor activity of CDK2 inhibitor BLU-222 plus CDK4/6 inhibitors for overcoming resistance in HR positive and triple negative metastatic #BreastCancer. bit.ly/49t9fj8 #AACR24

Tweet Image 1

Come by our CDK2 inhibitor poster #4622 Section 25 #AACR24 on @BlueprintMeds BLU222 inhibitor and find out why it is synergistic with CDK4/6i in both ER+ and TNBCs. @kandymarsy @MDAndersonNews @KellyKhunt @junay_14 @kettnernm #EndCancer


Come by the @BlueprintMeds poster #1959 (section #25 Board #8) at 9:00 am today @AACR24 to find the latest on the CDK2 inhibitor BLU-222-collaboration with @kandymarsy at @MDAndersonNews


In collaboration with @blueprintMeds new preclinical data on BLU-222, a CDK2 inhibitor is being presented at #AACR24 by the @kandymarsy @KellyKhunt labs from @MDAndersonNews-poster #4622 highlighting underlying mechanisms providing evidence for the ongoing VELA trial.

CDK2 is a key driver of tumor growth in HR+/HER2- metastatic breast cancer. We're committed to exploring new avenues for treating this cancer that may overcome resistance. Learn about our CDK2 inhibitor in development at #AACR24.



very proud of the post-docs from the KeyHunt lab, Dr. Mi Li, pictured below and Dr. Mei-Kuang Chen and Dr. Linjie Luo (oral presentation) who shined at the @MDAndersonNews trainee research day @KellyKhunt

Great to see our postdoctoral fellows and graduate medical education trainees share their outstanding research at today’s @MDAndersonNews Trainee Research Day presentation and poster sessions. Thank you to all who participated!

Tweet Image 1
Tweet Image 2
Tweet Image 3


Khandan Keyomarsi Reposted

It was an honor to present our recent findings at the #SSO2024 highlighting the work from @ndttuyen and @junay_14 @MDAndersonNews @KellyKhunt


Khandan Keyomarsi Reposted

#SSO2024 I really enjoyed the talk by @kandymarsy Especially how she highlighted researchers/mentees who have led the work under her leadership and guidance.

Tweet Image 1
Tweet Image 2

#SSO2024 John Wayne Clinical Research Lecture Phenomenal talk by @kandymarsy "Targeting the Cell Cycle Machinery in Cancer- From Bench to the Clinic and Back” Epitome of impactful translational research that is changing standard of care in treatment of sarcoma & breast cancer.

Tweet Image 1
Tweet Image 2
Tweet Image 3


The 4 CPRIT/CURE (mdanderson.org/education-trai…) and , UPWARDS (mdanderson.org/education-trai…) students pictured below (Mahdia Rahman; Grace Dealessandro, Chien MT Phuoc; Nicole Missouri) from the KeyHunt lab (mdanderson.org/research/depar…) gained valuable experience from their summer experience.

Generous donations from people like you help fuel research advances that can #EndCancer. If you’re able, make a year-end gift to MD Anderson today: brnw.ch/21wFEBr

Tweet Image 1


May this holiday season bring joy, reflection, and inspiration to all! Here's wishing you a festive break filled with laughter and good company. The KeyHunt lab (lnkd.in/gvKQsKvE) is excited for the year ahead, full of promising scientific endeavors.

Tweet Image 1

Khandan Keyomarsi Reposted

The annual K12 Calabrese and Physician scientists summit. What an amazing group of scholars! The force is strong and the future is bright here at MDACC!! @MDAndersonNews

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Loading...

Something went wrong.


Something went wrong.